Authors: Bakheit, AMO Bower, E Cosgrove, A Fox, M Morton, R Phillips, S Scrutton, D Shrubb, V Yude, C

Citation: Amo. Bakheit et al., Opinion statement on the minimal acceptable standards of healthcare in cerebral palsy, DISABIL REH, 23(13), 2001, pp. 578-582

Authors: Bakheit, AMO Severa, S Cosgrove, A Morton, R Roussounis, SH Doderlein, L Lin, JP

Citation: Amo. Bakheit et al., Safety profile and efficacy of botulinum toxin A (dysport) in children with muscle spasticity (vol 43, pg 234, 2001), DEVELOP MED, 43(5), 2001, pp. 357-357

Authors: Bakheit, AMO Severa, S Cosgrove, A Morton, R Rousso, SH Doderlein, L Lin, JP

Citation: Amo. Bakheit et al., Safety profile and efficacy of botulinum toxin A (Dysport(a)) in children with muscle spasticity, DEVELOP MED, 43(4), 2001, pp. 234-238

Authors: Eames, MHA Cosgrove, A Baker, R

Citation: Mha. Eames et al., Comparing methods of estimating the total body centre of mass in three-dimensions in normal and pathological gaits, HUMAN MOVE, 18(5), 1999, pp. 637-646

Authors: Eames, NWA Baker, R Hill, N Graham, K Taylor, T Cosgrove, A

Citation: Nwa. Eames et al., The effect of botulinum toxin A on gastrocnemius length: magnitude and duration of response, DEVELOP MED, 41(4), 1999, pp. 226-232